Chelating agents have long been used in the pharmacological treatment
of lead poisoning, whose management is still a problem, particularly i
n developing countries. This article reviews the pharmacological prope
rties of dimercaprole, penicillamine, CaNa2EDTA and dimercaprosuccinic
acid, examines their indications, contraindications and side effects
and discusses the possible use of each drug in occupational Pb poisoni
ng. Proposals are also presented for the treatment and follow-up of su
bjects with signs and symptoms of poisoning and of subjects with low-m
oderate Pb absorption. CaNa2EDTA seems to be the most reliable and saf
er chelating agent nowadays available and with a wider spectrum of act
ion. DMSA seems to be promising in the treatment of occupational Pb po
isoning. Even though there is no doubt that chelation therapy has sign
ificantly contributed to reduce mortality and morbidity from occupatio
nal Pb poisoning, the efficacy of this treatment in subjects with subt
le neurological or renal damage has not yet been studied properly.